Inactive
Notice ID:NIHODOLAOIlluminaInc05082020
This is NOT a solicitation for proposals, proposal abstracts, or quotations. This pre-solicitation, sources sought/notice of intent that is being conducted in part as a market survey to find other qua...
This is NOT a solicitation for proposals, proposal abstracts, or quotations. This pre-solicitation, sources sought/notice of intent that is being conducted in part as a market survey to find other qualified organizations that could fulfill this requirement apart from Illumina, Inc.. Small business concerns, 8(a) small businesses, Woman-owned, small disadvantaged businesses, HUBZone small businesses and Service-disabled Veteran small business concerns with the appropriate corporate infrastructure and operational capabilities to adequately provide the services described in the Statement of Work and specifications should respond to this notice. The intended procurement will be classified under NAICS 621511. If no other qualified providers can be located, the National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate on a sole source basis with Illumina, Inc. for the procurement of a High-throughput Illumina NovaSeq6000 DNA sequencer, pursuant to Federal Acquisition Regulation FAR) 6.302-1. This procurement will provide the National Institute of Health and Human Development (NICHD) Molecular Genomics Core (MGC) DNA Sequencing Facility to provide the same high level of throughput and accuracy and to assure continuity of on-going research.